DK2848625T3 - Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner - Google Patents

Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner Download PDF

Info

Publication number
DK2848625T3
DK2848625T3 DK14189582.1T DK14189582T DK2848625T3 DK 2848625 T3 DK2848625 T3 DK 2848625T3 DK 14189582 T DK14189582 T DK 14189582T DK 2848625 T3 DK2848625 T3 DK 2848625T3
Authority
DK
Denmark
Prior art keywords
contaminant
displacement
methods
ion exchange
naturally occurring
Prior art date
Application number
DK14189582.1T
Other languages
Danish (da)
English (en)
Inventor
Jerome Bill Jr
Timothy Tully
Christopher Dowd
Arick Brown
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39899038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2848625(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK2848625T3 publication Critical patent/DK2848625T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK14189582.1T 2008-08-14 2008-08-14 Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner DK2848625T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08797895.3A EP2321337B2 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using protein displacement ion exchange membrane chromatography
EP14189582.1A EP2848625B1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
PCT/US2008/073179 WO2010019148A1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography

Publications (1)

Publication Number Publication Date
DK2848625T3 true DK2848625T3 (da) 2019-10-07

Family

ID=39899038

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19181531.5T DK3604324T3 (da) 2008-08-14 2008-08-14 Fremgangsmåder til at fjerne en kontaminant under anvendelse af ionbytningskromatografi med forskydning af iboende proteiner
DK14189582.1T DK2848625T3 (da) 2008-08-14 2008-08-14 Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK19181531.5T DK3604324T3 (da) 2008-08-14 2008-08-14 Fremgangsmåder til at fjerne en kontaminant under anvendelse af ionbytningskromatografi med forskydning af iboende proteiner

Country Status (22)

Country Link
US (2) US10927144B2 (enExample)
EP (3) EP3604324B1 (enExample)
JP (1) JP5666447B2 (enExample)
KR (3) KR20180033311A (enExample)
CN (1) CN102149724B (enExample)
AU (1) AU2008360625C1 (enExample)
BR (1) BRPI0823046B1 (enExample)
CA (1) CA2731943C (enExample)
CY (1) CY1122221T1 (enExample)
DK (2) DK3604324T3 (enExample)
ES (3) ES2749190T3 (enExample)
FI (1) FI3604324T3 (enExample)
HR (2) HRP20240472T1 (enExample)
HU (2) HUE066562T2 (enExample)
IL (2) IL210912B (enExample)
LT (2) LT3604324T (enExample)
MX (1) MX2011001506A (enExample)
PL (2) PL2848625T3 (enExample)
PT (2) PT3604324T (enExample)
RS (1) RS59232B1 (enExample)
SI (2) SI2848625T1 (enExample)
WO (1) WO2010019148A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
EP2500413A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
US10927144B2 (en) 2008-08-14 2021-02-23 Genentech, Inc. Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
SG10201702951RA (en) 2008-10-20 2017-06-29 Abbvie Inc Viral inactivation during purification of antibodies
JP5808249B2 (ja) 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインａアフィニティークロマトグラフィーを用いる抗体の単離および精製
SG10201710439UA (en) † 2010-05-25 2018-01-30 Genentech Inc Methods of purifying polypeptides
WO2012030512A1 (en) * 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
KR20140092227A (ko) * 2010-12-10 2014-07-23 트레이시 톰슨 분리 방법용 조성물
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
PL2794635T3 (pl) 2011-12-22 2019-02-28 F.Hoffmann-La Roche Ag Membranowa chromatografia jonowymienna
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
EP2961759A4 (en) * 2013-02-26 2016-09-28 Agency Science Tech & Res PROTEIN CLEANING IN THE PRESENCE OF NON-ORGANIC POLYMERS AND ELECTROPOSITIVE SURFACES
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US10400007B2 (en) * 2013-04-16 2019-09-03 Asahi Kasei Medical Co., Ltd. Method for purifying antibody protein
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
US9546208B2 (en) 2014-01-03 2017-01-17 Bio-Rad Laboratories, Inc. Removal of impurities from protein A eluates
EP4389757A3 (en) * 2016-09-07 2025-01-01 GlaxoSmithKline Intellectual Property Development Limited Methods for purifying antibodies
JP7085533B2 (ja) 2016-09-09 2022-06-16 スリーエム イノベイティブ プロパティズ カンパニー 官能化コポリマー及びその使用
US10053368B1 (en) * 2017-09-07 2018-08-21 Chevron U.S.A. Inc. Synthesis of AFX framework type molecular sieves
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
TWI814812B (zh) * 2018-05-02 2023-09-11 美商里珍納龍藥品有限公司 用於評估生化過濾器的適合性的方法
EP3810650A1 (en) * 2018-06-19 2021-04-28 Bristol-Myers Squibb Company Methods of purifying proteins using chromatography
CN109324143B (zh) * 2018-10-19 2021-10-29 张骐 利用二维液相分离制备抗体类产品相关杂质的方法
CN109806916B (zh) * 2019-03-15 2021-12-21 中科森辉微球技术（苏州）有限公司 高性能阴离子交换介质及其制备方法
GB201911685D0 (en) * 2019-08-15 2019-10-02 Fujifilm Diosynth Biotechnologies Uk Ltd Process for purifying monoclonal antibodies
KR20220112014A (ko) 2021-02-03 2022-08-10 고인석 십전대보탕을 이용하여 만든 오리목뼈 간식
JP2024537490A (ja) * 2021-10-27 2024-10-10 プラズマ テクノロジーズ エルエルシー タンパク質を単離するための構成及び方法
CN118290514B (zh) * 2024-06-05 2025-04-04 东曜药业有限公司 基于阴离子膜的抗体偶联药物的纯化方法及抗体偶联药物

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4347322A (en) † 1981-01-12 1982-08-31 Nabisco Brands, Inc. Chromatographic process for enzyme purification
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
JP2749167B2 (ja) 1988-06-21 1998-05-13 ジェネンテク，インコーポレイテッド 心筋梗塞の処置のための方法および治療用組成物
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
AU2498192A (en) 1991-08-14 1993-03-16 Genentech Inc. Immunoglobulin variants for specific fc epsilon receptors
EP1136556B1 (en) 1991-11-25 2005-06-08 Enzon, Inc. Method of producing multivalent antigen-binding proteins
JPH08500962A (ja) 1992-02-06 1996-02-06 クリエイティブ バイオモレキュルズ，インコーポレイテッド 癌マーカー用生物合成結合蛋白質
ZA936128B (en) 1992-08-21 1995-02-20 Genentech Inc Method for treating a LFA-1 mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5714338A (en) 1993-12-10 1998-02-03 Genentech, Inc. Methods for diagnosis of allergy
DK0739214T3 (da) 1994-01-18 1998-10-07 Genentech Inc Fremgangsmåde til behandling af parasitinfektionerunder anvendelse af IgE antagonister
EP0749488A1 (en) 1994-03-03 1996-12-27 Genentech, Inc. Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
WO1996040210A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
IL125255A (en) 1996-01-23 2002-02-10 Genentech Inc Anti-cd18 antibodies for treating stroke
AU1458497A (en) 1996-01-31 1997-08-22 John Stephen Ayers Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
EP1516629B1 (en) 1996-11-27 2013-04-03 Genentech, Inc. Humanized anti CD-11a antibodies
DK1325932T5 (da) 1997-04-07 2005-10-03 Genentech Inc Anti-VEGF antistoffer
ES2293682T5 (es) 1997-05-15 2011-11-17 Genentech, Inc. Anticuerpo anti-apo2.
US6489447B1 (en) * 1998-05-06 2002-12-03 Genentech, Inc. Protein purification
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
AU778199B2 (en) 1999-10-29 2004-11-25 Genentech Inc. Anti-prostate stem cell antigen (PSCA) antibody compositions and methods of use
US6479636B1 (en) * 2000-04-11 2002-11-12 Honiron Corporation (A Louisiana Corporation) Sugarcane fractioning system
US6633462B2 (en) 2000-07-13 2003-10-14 Koninklijke Philips Electronics N.V. Magnetoresistive angle sensor having several sensing elements
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
GB2372464B (en) * 2001-02-22 2003-05-14 Vivascience Ltd Method of isolating a charged compound
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
EP1507793A4 (en) 2001-10-17 2006-02-01 Human Genome Sciences Inc NEUTROKIN ALPHA AND NEUTROKIN ALPHA SPLICE VERSION
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
CN100522999C (zh) 2002-02-14 2009-08-05 免疫医疗公司 抗cd20抗体及其融合蛋白和使用方法
AU2003265235A1 (en) † 2002-04-26 2003-12-19 Genetech, Inc. Non-affinity purification of proteins
WO2004024752A1 (ja) * 2002-09-11 2004-03-25 Chugai Seiyaku Kabushiki Kaisha タンパク質精製方法
ES2744275T3 (es) 2002-10-17 2020-02-24 Genmab As Anticuerpos monoclonales humanos contra CD20 para su uso en el tratamiento de esclerosis múltiple
DE60332957D1 (de) 2002-12-16 2010-07-22 Genentech Inc Immunoglobulinvarianten und deren verwendungen
WO2005000901A2 (en) 2003-05-09 2005-01-06 Duke University Cd20-specific antibodies and methods of employing same
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
CA2534898A1 (en) 2003-08-08 2005-02-17 Immunomedics, Inc. Bispecific antibodies for inducing apoptosis of tumor and diseased cells
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
BR122020007658B1 (pt) † 2003-10-27 2021-07-27 Wyeth Método para a remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatita
MX2007009466A (es) 2005-02-10 2007-12-07 Baylor Res Inst Anticuerpos monoclonales de anti-interferon alfa y metodos para su uso.
RU2457214C2 (ru) † 2005-03-11 2012-07-27 Вайет Способ хроматографии в режиме слабого распределения
CA2645739A1 (en) 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
WO2009135656A1 (en) 2008-05-06 2009-11-12 Lonza Biologics Plc. A method for the purification of antibodies using displacement chromatography
US10927144B2 (en) 2008-08-14 2021-02-23 Genentech, Inc. Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
US9813410B2 (en) 2014-06-26 2017-11-07 Rakuten, Inc. Information processing apparatus, information processing method, and information processing program

Also Published As

Publication number Publication date
EP2848625A1 (en) 2015-03-18
ES2527943T3 (es) 2015-02-02
US10927144B2 (en) 2021-02-23
LT3604324T (lt) 2024-05-10
CA2731943A1 (en) 2010-02-18
SI3604324T1 (sl) 2024-06-28
AU2008360625A1 (en) 2010-02-18
EP2321337B1 (en) 2014-10-22
CY1122221T1 (el) 2020-11-25
LT2848625T (lt) 2019-10-10
HUE047316T2 (hu) 2020-04-28
ES2978373T3 (es) 2024-09-11
FI3604324T3 (fi) 2024-05-16
EP3604324B1 (en) 2024-02-28
WO2010019148A1 (en) 2010-02-18
EP3604324A1 (en) 2020-02-05
HRP20240472T1 (hr) 2024-06-21
PL2848625T3 (pl) 2020-01-31
IL210912B (en) 2019-03-31
EP2848625B1 (en) 2019-07-31
JP5666447B2 (ja) 2015-02-12
KR102196883B1 (ko) 2020-12-30
JP2011530592A (ja) 2011-12-22
HUE066562T2 (hu) 2024-08-28
ES2527943T5 (es) 2019-03-07
EP2321337A1 (en) 2011-05-18
SI2848625T1 (sl) 2019-11-29
US20210284685A1 (en) 2021-09-16
AU2008360625C1 (en) 2017-01-19
CN102149724A (zh) 2011-08-10
PL3604324T3 (pl) 2024-07-01
AU2008360625B2 (en) 2016-05-19
US20120122759A1 (en) 2012-05-17
ES2749190T3 (es) 2020-03-19
PT3604324T (pt) 2024-05-10
EP2321337B2 (en) 2018-10-10
RS59232B1 (sr) 2019-10-31
KR20110067099A (ko) 2011-06-21
CA2731943C (en) 2016-11-29
DK3604324T3 (da) 2024-04-08
IL262657A (en) 2018-12-31
IL262657B (en) 2021-03-25
BRPI0823046A2 (pt) 2015-07-28
KR20180033311A (ko) 2018-04-02
IL210912A0 (en) 2011-04-28
BRPI0823046B1 (pt) 2021-12-14
KR101843915B1 (ko) 2018-04-02
MX2011001506A (es) 2011-03-15
HK1210181A1 (en) 2016-04-15
EP2321337B9 (en) 2016-11-30
CN102149724B (zh) 2014-04-09
KR20180137591A (ko) 2018-12-27
PT2848625T (pt) 2019-10-25
HRP20191848T1 (hr) 2019-12-27

Similar Documents

Publication Publication Date Title
DK2848625T3 (da) Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner
DK2094376T3 (da) Membrandestillationsfremgangsmåde til rensning af en væske
DK2183640T3 (da) Fremgangsmåde til udformning af multifokale kontaktlinser
DK2467204T3 (da) Fremgangsmåde til fremstilling af en sorbent
EP2160227A4 (en) chromatographic methods
DK2513135T3 (da) Fremgangsmåde til oprensning af polypeptider
DK2167613T3 (da) Fremgangsmåde til fremstilling af biobrændsler
DK1996923T3 (da) Fremgangsmåder til adskillelse af isomerer ved hjælp af massespektrometri
IL211217A0 (en) Methods for evaluating chromatography column performance
DK2313364T3 (da) Fremgangsmåder til detektering af symmetrisk demethylarginin
SG173491A1 (en) Membrane with sulfonic groups for removing protein aggregates
BRPI0809206A2 (pt) Processo de formação de membranas microporosas
EP2223736A4 (en) TAUCHMEMBRANABSCHEIDER
DK2361388T3 (da) Fremgangsmåder til karakterisering af molekyler
FI20075465L (fi) Talteenottomenetelmä
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
EP2044225A4 (en) SEPARATION
DK2175739T3 (da) Fremgangsmåde til fremstilling af ost
DK2171474T3 (da) Fremgangsmåde til bestemmelse af koncentrationen af et molekyle
DK2279545T3 (da) Kontaktenhed og fremgangsmåde til fremstilling af en kontaktenhed
DK2317877T3 (da) Fremgangsmåde til filtrering af mælk
DK2416672T3 (da) Fremgangsmåde til at gøre biologiske cellers membraner gennemtrængelige ved anvendelse af et pulseret elektrisk felt
DK2094366T3 (da) Fremgangsmåde til oprensning af sialyllactose ved chromatografi
DK2213747T3 (da) Fremgangsmåde til fremstilling af membranprotein
DK2032230T3 (da) Fremgangsmåde til optimering af kromatografiske oprensningsfremgangsmåder til biomolekyler